Home › Markets › Health Care › INMD

InMode Ltd. (INMD)

INMD trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$14.30
+0.04% on the day
Market cap
$822.3M
Small cap
Revenue · 2025
$370.5M
-6.2% on 2024
Net income · 2025
Net income not in SEC XBRL data
0.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerINMD on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryIsrael
IPO year2019
SEC CIK0001742692
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inL3

Financials · 2025

LineValue
Revenue$370.5M
Net incomeNot in SEC XBRL data
Operating income$85.4M
Net margin0.0%
Operating margin23.0%
Revenue growth-6.2%
Cash$302.5M
Total assets$766.4M
P/E (computed)Net income was not positive
P/S (computed)2.2×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42019-08-08
Latest annual report20-F2026-02-10
Latest quarterly / interim6-K2026-09-16

Source: SEC EDGAR submissions feed, 154 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.7%
1 month-4.1%
3 months-8.6%
Year to date-3.0%
1 year-6.8%
From 52-week high-14.2%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
CBLLCeriBell Inc.$26.14+3.48%$1.0B
CNMDCONMED Corporation$45.55+0.42%$1.4B
CVCapsoVision Inc.$6.78+0.30%$360.7M
AXGNAxogen Inc.$36.17-2.53%$2.1B
TMDXTransMedics Group Inc.$79.14+1.23%$2.7B
ELMDElectromed Inc.$27.68-1.53%$229.4M
FOCLEDAP TMS S.A.$4.20-2.33%$193.0M
LIVNLivaNova PLC$76.37-1.17%$4.2B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier